focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EVRAZ holds Capital markets day

18 Oct 2019 07:00

RNS Number : 3104Q
Evraz Plc
18 October 2019
 

EVRAZ holds Capital markets day

 

18 October 2019 EVRAZ plc (LSE: EVR) ("EVRAZ" or the "Company") announces that it will be hosting its annual Capital Markets Day at 9:00 am in London today.

 

The Capital Markets Day will feature presentations by EVRAZ executives, including Sir Michael Peat (Senior Independent Non-Executive Director), Alexander Frolov (CEO), Alexey Ivanov (Senior Vice-President, Commerce and Business development), Nikolay Ivanov (CFO) and Artem Natrusov (Vice-President, Information Technologies).

 

The presentation will provide an overview of global steel and raw material market trends and EVRAZ' strategic goals. Management will discuss CAPEX program and give an update on major development projects in Russia and North America.

 

For 2020-23 period, EVRAZ is considering three major investment projects with the target to increase sales of finished steel products. Capital expenditures are expected to be around US$1.0 billion per annum during 2020-2023. In 2019, capital expenditures level is estimated at c.US$850 million.

The Company expects that in 2019 the effect on EBITDA from efficiency improvement program, which includes the customer focus and cost saving initiatives, will be around US$350 million. The target is to maintain the pace of improvements with the effect of at least 3% from COGS or c.US$300 million per annum going forward. Already identified effect from initiatives for 2019-24 is approximately US$260 million per annum on average.

 

Webcast and presentation:

A live webcast of the presentations will begin at 09:00am BST and will be accessible via the following link:

https://webcasting.brrmedia.co.uk/broadcast/5d947208f8cc7162f3b010b4

 

The presentation could be downloaded here:

http://www.rns-pdf.londonstockexchange.com/rns/3104Q_1-2019-10-17.pdf

 

The presentation will be also available on the Company's website: 

https://www.evraz.com/en/investors/reports-and-results/presentations/#2019

 

 

###

 

For further information:

 

Media Relations:

Vsevolod Sementsov

VP, Corporate Communications

London: +44 207 832 8998 Moscow: +7 495 937 6871

media@evraz.com

 

Investor Relations:

Irina Bakhturina

Director, Investor Relations

London: +44 207 832 8990 Moscow: +7 495 232 1370

ir@evraz.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMRBBTMBJBTPL
Date   Source Headline
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 201910:00 amRNSEXERCISE OF PUT OPTION IN RESPECT OF YGOK SHARES
27th Mar 20199:30 amRNSStabilisation Notice
27th Mar 20198:07 amRNSEvraz Plc Announces Tender Offer Results
27th Mar 20197:09 amRNSEVRAZ announces pricing of U.S.$700m note issue
26th Mar 20199:37 amRNSStabilisation Notice
22nd Mar 20196:28 pmRNSHolding(s) in Company
22nd Mar 20196:27 pmRNSHolding(s) in Company
19th Mar 20196:30 pmRNSHolding(s) in Company
19th Mar 20197:41 amRNSDirector/PDMR Shareholding
19th Mar 20197:33 amRNSCompletion of sale of existing shares of EVRAZ
18th Mar 20194:46 pmRNSIntended sale of existing ordinary shares of EVRAZ
18th Mar 201910:02 amRNSAnnouncement of Tender Offer
13th Mar 20192:40 pmRNSEurobonds Issuer Substitution
13th Mar 20197:35 amRNSDividend - determination of currency amounts
28th Feb 20197:00 amRNSAnnual Financial Report
20th Feb 20198:10 amRNSNOTICE OF 2018 RESULTS AND CONFERENCE CALL DETAILS
31st Jan 20199:00 amRNSEVRAZ Q4 2018 TRADING UPDATE
28th Jan 20196:00 pmRNSHolding(s) in Company
28th Jan 20196:00 pmRNSShareholding notification
27th Dec 20183:42 pmRNSAmendment of transshipment agreement
27th Dec 20187:00 amRNSResponse to Press Speculation
27th Dec 20187:00 amRNSDirector/PDMR Shareholding
24th Dec 20187:04 amRNSHolding(s) in Company
24th Dec 20187:02 amRNSHolding(s) in Company
24th Dec 20187:00 amRNSMajor shareholding notification
28th Nov 20184:20 pmRNSDividend - determination of currency amounts
15th Nov 201812:03 pmRNSThird interim dividend for 2018
25th Oct 20189:45 amRNSEVRAZ Q3 2018 TRADING UPDATE
19th Oct 20187:00 amRNSEVRAZ plc holds Investor Day
17th Oct 201810:03 amRNSDirector/PDMR Shareholding
20th Sep 20183:24 pmRNSUpdate on relationship agreements
10th Sep 20186:00 pmRNSDirector/PDMR Shareholding
4th Sep 201811:22 amRNSHolding(s) in Company
4th Sep 201811:18 amRNSHolding(s) in Company
4th Sep 201811:16 amRNSHolding(s) in Company
4th Sep 201811:15 amRNSMajor shareholding notification
22nd Aug 20183:54 pmRNSDividend - Determination of Currency Amounts
9th Aug 20187:00 amRNSHalf-year Report
8th Aug 20183:34 pmRNSChanges to the Board of Directors
26th Jul 20187:00 amRNSEVRAZ Q2 2018 TRADING UPDATE
19th Jul 20184:20 pmEQSNOTICE OF H1 2018 RESULTS AND CONFERENCE CALL DETAILS
10th Jul 20185:00 pmRNSResult of Court Hearing - Reduction of Capital
26th Jun 20186:30 pmRNSDirector/PDMR Shareholding
25th Jun 201810:20 amRNSEVRAZ Modern Slavery Transparency Statement 2017
19th Jun 201812:47 pmRNSResult of AGM
19th Jun 201810:27 amRNSProvision of guarantee
19th Jun 201810:21 amRNSResults of the General Meeting of shareholders
13th Jun 20185:00 pmRNSReport on payments to governments for 2017
13th Jun 20189:25 amRNSDividend - Determination of Currency Amounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.